Empagliflozin restores cardiac function in obese-diabetic HFpEF mice but further alters gene expression - Top-Institutions - MDSpire

Empagliflozin restores cardiac function in obese-diabetic HFpEF mice but further alters gene expression

  • By

  • Juliana Mira Hernandez

  • Logan R. J. Bailey

  • Victoria R. Salemme

  • Christopher Y. Ko

  • Erin Y. Shen

  • Megan Ngim

  • Duong T. Hoang

  • Melissa Corea

  • Julie Bossuyt

  • Jennifer M. Davis

  • Donald M. Bers

  • Bence Hegyi

  • May 21, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    University of California, Davis
    University of California, Davis

    Davis, California

    Key Differentiators

    • Cardiology

  • #2

    Université Claude Bernard Lyon 1
    Université Claude Bernard Lyon 1

    Lyon, Auvergne-Rhône-Alpes

    Key Differentiators

    • Cardiology

  • #3

    Queen’s University Belfast
    Queen’s University Belfast

    Belfast, Northern Ireland

    Key Differentiators

    • Cardiology

  • #4

    Landesuntersuchungsamt Rheinland-Pfalz
    Landesuntersuchungsamt Rheinland-Pfalz

    Trier, Rheinland-Pfalz

    Key Differentiators

    • Cardiology

  • #5

    Charles River
    Charles River

    Sulzfeld, Baden-Württemberg

    Key Differentiators

    • Cardiology

Original Source(s)

Empagliflozin restores cardiac function in obese-diabetic HFpEF mice but further alters gene expression

  • by Juliana Mira Hernandez, Logan R. J. Bailey, Victoria R. Salemme, Christopher Y. Ko, Erin Y. Shen, Megan Ngim, Duong T. Hoang, Melissa Corea, Julie Bossuyt, Jennifer M. Davis, Donald M. Bers, Bence Hegyi

  • May 21, 2026

Related Content

MRI staging of haemodynamic congestion and clinical outcomes

Cardiovascular sequelae of Long COVID: immune dysregulation inflammation as central drivers

Association of estimated glomerular filtration rate and in-hospital mortality in patients hospitalized for heart failure: a retrospective cohort study